PNC Financial Services Group’s NexImmune, Inc. Common Stock NEXI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-12,640
Closed -$34.9K 4974
2024
Q2
$34.9K Hold
12,640
﹤0.01% 3205
2024
Q1
$70.9K Hold
12,640
﹤0.01% 2804
2023
Q4
$28.1K Sell
12,640
-2
-0% -$7 ﹤0.01% 3251
2023
Q3
$66.4K Hold
12,642
﹤0.01% 2805
2023
Q2
$89.1K Hold
12,642
﹤0.01% 2715
2023
Q1
$120K Buy
12,642
+5,945
+89% +$62.4K ﹤0.01% 2461
2022
Q4
$40.7K Buy
6,697
+2,222
+50% +$27.7K ﹤0.01% 3099
2022
Q3
$62K Hold
4,475
﹤0.01% 2838
2022
Q2
$180K Hold
4,475
﹤0.01% 2219
2022
Q1
$471K Buy
4,475
+3,804
+567% +$279K ﹤0.01% 1695
2021
Q4
$77K Buy
+671
New +$161K ﹤0.01% 2865

Other funds holding NEXI

PNC Financial Services Group's NEXI Position: Q3 2024 in Review

PNC Financial Services Group sold out of NexImmune, Inc. Common Stock (NEXI) in Q3 2024, closing a stake of 12,640 shares — an estimated $34.9K sold.

PNC Financial Services Group first reported a position in NEXI in Q4 2021 and held it in 11 quarters. The position peaked at $471K in Q1 2022. 1 fund tracked by Wall St. Rank holds NEXI as of Q3 2024.

  • PNC Financial Services Group reported no remaining NexImmune, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • PNC Financial Services Group sold 12,640 NexImmune, Inc. Common Stock shares in Q3 2024, an estimated $34.9K.
  • PNC Financial Services Group first reported a position in NexImmune, Inc. Common Stock in Q4 2021 and held it in 11 quarters.
  • PNC Financial Services Group's NexImmune, Inc. Common Stock position peaked at $471K in Q1 2022.
  • 1 fund tracked by Wall St. Rank held NexImmune, Inc. Common Stock as of Q3 2024.

Based on PNC Financial Services Group's 13F filing for Q3 2024, filed 8 Nov 2024.